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Abstract
Background: Prader-Willi syndrome is a rare genetic abnormality that can be challenging to diagnose early, but for
which early interventions improve prognosis.
Methods: To improve understanding of Prader–Willi syndrome in neonates in Asia, we retrospectively analyzed the
clinical records of 20 affected newborns diagnosed in the Department of Neonatology, Guangzhou Women and
Children’s Medical Center, Guangzhou, China from January 2007 to December 2014 and performed a review of the
relevant literature.
Results: Fourteen boys and six girls presented with hypotonia, poor responsiveness, feeding difficulty, and infrequent,
weak crying. Different from western patients, the 20 Asian patients exhibited at least five of the following typical
features: prominent forehead, narrow face, almond-shaped eyes, small mouth, downturned mouth, thin upper lip,
and micromandible. All 14 boys had a small scrotum, including nine with cryptorchidism. Diagnoses were made with
microarray comparative genomic hybridization. All 20 infants required feeding tubes. Fifteen received swallowing
training immediately after admission; the period of continuous tube feeding for these patients ranged from 8 to 22
days (mean, 14 ± 5.3 days). For the five patients who did not receive swallowing training, the period of continuous
tube feeding ranged from 15 to 35 days (mean, 18 ± 4.3 days). Comprehensive care measures included: giving parents
detailed health education and basic information about this disease, teaching skills to promote feeding and prevent
suffocation, increasing children’s passive activity, providing nutrition management for normal development, and
preventing excessive or inadequate nutrient intake.
Conclusions: Neonates with Prader–Willi syndrome in Asia have hypotonia, poor responsiveness, feeding difficulty,
infrequent and weak crying, genital hypoplasia, and characteristic facial features. Recognition of the syndrome in
neonates with confirmation by genetic testing is essential, because early diagnosis allows early intervention. Treatment
measures including swallowing training can improve prognosis, prevent growth retardation and obesity, and elevate
quality of life in individuals with Prader–Willi syndrome.
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Background
Prader–Willi syndrome (PWS) is a complex multisystem
abnormality, first reported by Prader and colleagues in
1956. The syndrome is generally caused by an abnormality
in the q11-13 region on paternal chromosome 15. The in-
cidence of PWS varies in different countries from 1 in
15,000 to 1 in 25,000, with an average mortality of 3 %
[1–3]. The main clinical features of affected individuals
include hypotonia, feeding difficulty, developmental delay,
short stature, abnormal behavior during the neonatal
period, obesity, poor hypothalamic and gonadal develop-
ment, and characteristic appearance during childhood [4].
There are few reports of the syndrome in Asia. There is
currently insufficient understanding of the signs and
symptoms of PWS in neonates, and the rate of early diag-
nosis is not high in Asia. Early diagnosis allows implemen-
tation of comprehensive treatment at an early stage, which
can improve growth and minimize developmental disor-
ders, improving prognosis. In this study we evaluated the
clinical manifestations of PWS in 20 neonates who were
treated in the Department of Neonatology, Guangzhou
Women and Children’s Medical Center, Guangzhou,
China. We also analyzed the relevant literature, and
present the features of and comprehensive intervention
measures for PWS in neonates in China.
Methods
Subjects
All neonates treated in the Department of Neonatology,
Guangzhou Women and Children’s Medical Center,
Guangzhou, China from January 2007 to December 2014
underwent comprehensive physical examination. Neo-
nates who exhibited prominent forehead, narrow face,
almond-shaped eyes, downturned mouth, thin upper lip,
micromandible, and/or small scrotum, cryptorchidism
and hypotonia were diagnosed with suspected PWS.
Clinical features
The appearances and characteristics in the 20 neonates
with PWS were summarized and analyzed.
Examination methods
Further examinations were performed in these cases,
including cranial magnetic resonance imaging; elec-
troencephalogram; chest X-rays; ultrasonography of the
cardiovascular system, urinary system and digestive sys-
tem; as well as tandem mass spectrometry for congenital
metabolic disorders. Affymetrix CytoScan 750K chip was
used to detect the variation in patients’ genome. Parental
health status was investigated to determine any history
of congenital, hereditary, or familial diseases, history of
pregnancy and delivery, and pregnancy complications.
All 20 patients were diagnosed with PWS based on
microarray comparative genomic hybridization within 2
months of birth. Comprehensive interventions were sim-
ultaneously instituted, including swallowing training and
physical therapy, with regular rehabilitation assessments.
Results
General data
Fourteen boys and six girls were hospitalized during the
neonatal period. Of the 20 cases, 16 were treated in the
Department of Neonatology immediately after birth be-
cause of poor responsiveness. Four left the hospital after
birth, but presented again because of poor feeding, one at
1 week, and the others at 2~4 weeks of age. Maternal age
ranged from 19 to 38 years (mean, 31.5 ± 5.4 years). Pater-
nal age ranged from 21 to 45 years (mean, 34.9 ± 8.2 years).
Parents were generally healthy, and with no history of con-
genital, hereditary, or familial diseases. Mothers of six of
the neonates had complained of infrequent fetal movement
during pregnancy. Mothers of eight of the neonates had
experienced polyhydramnios. None of the mothers had
experienced pregnancy complications. Gestational age
ranged from 32 to 42 weeks (mean, 38.5 ± 2.7 weeks). Four
babies were born at 32~36 weeks (premature birth). The
remaining 16 were full term. Five infant was delivered by
spontaneous delivery; 15 were delivered by cesarean
delivery. Mean birth weight was 2732 ± 265 g. Two patients
were full-term small-for-gestational-age infants. Three had
mild asphyxia at birth; the remaining 17 did not.
Features during the neonatal period
All 20 neonates presented with hypotonia, poor respon-
siveness, feeding difficulty, and infrequent and weak cry-
ing. Hypotonia resulted in the unusual sleeping posture
of bilateral hip valgus and weakness of limbs (Fig. 1). All
patients exhibited at least five of the following typical
facial features, in order from most to least common,
included: prominent forehead, almond-shaped eyes,
downturned mouth, narrow face, thin upper lip, micro-
mandible, and small mouth (Table 1, Fig. 1). All 14
boys had small scrota, including nine with cryptorchid-
ism. The genitalia of one girl had the appearance of
labia minora.
Treatment and examination results
All 20 patients presented with feeding difficulty and re-
quired feeding tubes. The period of continuous tube
feeding ranged from 8 to 35 days (mean, 19 ± 8.5 days).
Fifteen neonates received swallowing training immedi-
ately after admission. For these 15, the period of con-
tinuous tube feeding ranged from 8 to 22 days (mean,
14 ± 5.3 days). For the five patients who did not receive
swallowing training, the period of continuous tube feed-
ing ranged from 15 to 35 days (18 ± 4.3 days). One of
the four premature infants received mechanical ventila-
tion, which was removed successfully on the 2nd day
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Fig. 1 Characteristic sleeping posture and scrotal and vulvar dysplasia in six neonates with Prader–Willi syndrome. a–e Cases 1–5, respectively.
All patients exhibited hypotonia, showing the characteristic sleeping posture of bilateral hip valgus and weakness of limbs. All patients exhibited
prominent forehead, almond-shaped eyes and downturned mouth. The boys had a small scrotum. Cases 2, 4, and 5 had cryptorchidism. f Case 9,
with hypotonia, bilateral hip valgus, and vulvar dysplasia
Table 1 Facial features and their prevalence among twenty neonates with Prader–Willi syndrome
Case Gender Prominent forehead Narrow face Almond-shaped eyes Small mouth Downturned mouth Thin upper lip Micromandible
1 Male + + + + + + −
2 Male + + + − + + +
3 Male + + + + + − +
4 Male + − + − + + +
5 Male + + + − + + +
6 Male + + + − + + +
7 Female + + + + + + −
8 Male + + + + + + +
9 Female + + + + + − −
10 Female + + + − + + +
11 Male + + + + + + −
12 Male + + + − + + +
13 Male + + + + + − +
14 Male + − + − + + +
15 Male + + + − + + +
16 Male + + + − + + +
17 Female + + + + + + −
18 Male + + + + + + +
19 Female + + + + + − −
20 Female + + + + + + −
Proportion 100 % 90 % 100 % 55 % 100 % 80 % 65 %
+: have this feature; −: do not have this feature
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after birth. No abnormal signs were detected in any of the
patients on cranial magnetic resonance imaging. Electro-
encephalogram revealed increased slow background activity
in 12 cases, mainly continuous low-amplitude electrical
activity of 3–10 Hz, mixed with increased low-amplitude
fast waves. Normal electroencephalogram waveforms were
found in eight cases. Chest X-rays showed consolidation
of both lungs in four patients, but no abnormality in the
others. Echocardiography revealed patent ductus arterio-
sus in three cases, and patent foramen ovale in six. Ultra-
sonography of the urinary and digestive systems was
normal in all cases. Tandem mass spectrometry showed a
small amount of hydroxy acid in the urine of two patients
with congenital metabolic diseases, and a small amount of
α-ketoglutarate in one patient, indicating a high catabolic
state. No organic acid metabolism was detected in the
other 17 cases. Length of hospital stay ranged from 10 to
38 days (mean, 21 ± 8.4 days).
Genetic analysis
Genetic analysis was performed with microarray compara-
tive genomic hybridization in all 20 neonates. There were
microdeletions in the paternal 15q11-13 region in 16 cases
(Fig. 2), and maternal homologous diploid in four cases.
Discussion
PWS is a complex disease affecting multiple body systems,
with variable clinical features in different growth stages.
Holm et al. [5] proposed the clinical diagnostic criteria for
PWS in 1993. These include a series of symptoms from
the perinatal period to adolescence; however, early diagno-
sis in neonates is difficult based on these criteria. A diag-
nosis of PWS is reliable at about 2.5 years of age [6], based
on a limited number of clinical studies in Asia. Most cases
are reported after the neonatal period. In seven studies,
patient age at final diagnosis ranged from 1 to 20 years
[7–13]; some of these patients presented because of de-
layed sexual development. Delays in diagnosis and treat-
ment affect patient prognosis and quality of life. Several
recent Asian studies have focused on PWS. However,
most have explored the genetic diagnosis of the syndrome,
and few have investigated manifestations and interven-
tions during the neonatal period. Early diagnosis and early
intervention greatly improve the prognosis of individuals
with PWS. [6] Therefore, it is important to summarize the
neonatal signs and symptoms of the syndrome in Asian,
to perform gene detection for suspected cases, and to edu-
cate physicians, especially neonatologists, about early diag-
nosis and intervention.
This study demonstrated that the major clinical fea-
tures of PWS in China include hypotonia, poor res-
ponsiveness, feeding difficulty, and infrequent crying; of
these, hypotonia and feeding difficulty are consistent
with the findings of previous studies [14–16]. Because of
hypotonia, both hips are slightly valgus, resulting in a
characteristic sleeping posture in neonates with PWS.
Less fetal movement and polyhydramnios are common
during pregnancy in women carrying an infant with
PWS, and are also associated with hypotonia and feeding
difficulty [17]. In the present study, all male patients had
a small scrotum, indicating that genital hypoplasia can be
considered a reference for diagnosis of PWS in the neo-
natal period. This series included only six female patients,
three of whom had vulvar dysplasia, so we cannot draw
conclusions about female genital characteristics associated
with the syndrome. A large sample study is needed.
For many years there has been controversy about the
characteristic facial features of individuals with PWS.
Gunay-Aygun et al. [4] retrospectively analyzed 90 cases
of PWS, and confirmed that detection of the syndrome
based on particular facial features had a sensitivity of only
49 %. All patients in this study exhibited at least five of the
typical facial features, which is consistent with the results
of a previous clinical study of five neonates with PWS
[18]. These findings suggest that craniofacial features have
a high specificity in neonates with PWS in Asia, and are
thus very important in diagnosing the syndrome during
the neonatal period. The difference of craniofacial features
among studies may depend on the different races. Most
previous studies [4, 5] were retrospective studies in chil-
dren or adults, and did not exclude atypical craniofacial
features resulting from childhood or adolescent obesity.
Fig. 2 Genotype in case 4: 46,XY. arr14q32.33(106,272,897-106,927,569)×3. arr15q11.2q13.1(23,290,787-28,540,345)×1. Approximately 655-kb repeat
in the q32.33 106,272,897-106,927,569 regions on chromosome 14; this repeat is polymorphic. Approximately 5.3-Mb deletion in the q11.2-q13.1
23, 290, 787-28, 540, 345 regions on chromosome 15; this deletion is pathogenic
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Wharton et al. [19] found that approximately 23 % of
patients with PWS experienced birth asphyxia; however,
Trifiro et al. [20] reported that patients did not suffer
from perinatal asphyxia or severe respiratory distress im-
mediately after birth. Three patients in the present study
experienced mild birth asphyxia, a proportion similar to
that in the report of Wharton et al. All had decreased
muscle tone, color, and responsiveness, which are inher-
ent characteristics of neonates with PWS, and have little
association with intrauterine or peripartum hypoxia.
None of the patients in this study experienced severe re-
spiratory distress. Cranial computed tomography did not
reveal signs of hypoxic brain damage. Therefore, we
conclude that asphyxia and hypoxia at birth are not very
common among neonates with PWS. A previous study
demonstrated that the incidence of congenital birth de-
fects such as congenital heart disease and spinal deform-
ity was higher among individuals with PWS and should
attract the attention of physicians [21].
Feeding difficulty is common among neonates with
PWS. The proportion of neonates with PWS requiring a
feeding tube is as high as 90–100 % in various studies. A
previous study demonstrated that the average period of
feeding tube use in neonates with PWS was 15 days
(range, 0–60 days) [6]. All 20 patients in this study re-
quired a feeding tube. It reveals that the swallowing cap-
ability of PWS neonates is weak regardless of different
races. The period of tube feeding was shorter for neo-
nates who received swallowing training than for those
who did not. However, the present study had a small
sample size; the effect of swallowing training should be
confirmed in a larger study. A correlation has been re-
ported between delayed language development and the
duration of tube feeding in neonates with PWS [6].
Thus, the period of tube feeding should be shortened,
and swallowing training can be conducted at an early
stage. In our present study, the patients received naso-
gastric tube feeding for a median duration of 18 ± 4.3
days. The duration of gastric tube feeding was similar
with N. Bachere’s cohort study. The duration of gastric
tube feeding tends to decrease, compared with historical
cohort, with the younger neonates being less tube-fed
than the older ones. This finding is of major importance,
as the specific speech and language problems observed
in previous patients could be worsened by a long
duration of tube feeding. In the future, it would be better
to try to avoid gastric feeding by teaching parents how
to encourage and optimize suckling.
There is no specific treatment for PWS, so combination
therapy is generally implemented. A previous study found
a positive therapeutic effect associated with shortening the
period of tube feeding, increasing growth in height, con-
trolling abnormal weight gain, and promoting normal
growth and development [6]. Parents need to receive
detailed health education, including basic information
about this disease. They also require instruction on pro-
moting feeding and preventing suffocation, increasing
children’s passive activity, providing nutrition manage-
ment for normal development, and preventing excessive
or inadequate nutrient intake. Exercise therapy was per-
formed twice weekly in the present study to improve
muscle tone and motor development. From the time of
diagnosis, many professionals are involved in the care of
children with PWS, including speech therapists, nutrition-
ists, neurologists, psychiatrists, psychologists, and ortho-
pedic surgeons. Previous studies have shown that the
incidence of systolic dysfunction is higher in infants with
PWS than in unaffected children. Thus, infants with PWS
should have cardiovascular, nutritional, endocrine, and
physical therapy visits every 3 months during the first year
of life. Rechecks can occur every 6 months after the first
year. Early diagnosis and intervention allow implementa-
tion of reasonable nutrition programs to prevent obesity,
improve learning, and assist the development of speech
[22, 23]. Regular and timely use of growth hormone (GH)
after early diagnosis not only promotes growth and im-
proves fat utilization, but also possibly elevates cognitive
level [24, 25]. GH treatment is beneficial for children with
PWS. It improves linear growth, body composition, phys-
ical strength and agility [26–28]. Fat utilization and resting
energy expenditure are increased by GH treatment, the
latter partially explained by an increment in lean body
mass [29–31]. According to observational data, GH treat-
ment is usually initiated at a mean age of 7 years, as re-
ported by Takeda et al. [32]. Increasingly, GH treatment is
initiated earlier [33–35]. Published data support benefits
of GH treatment when started between 4 and 6 months of
age [36, 37], but some experts are currently treating from
as early as 3 months. No consensus was reached on age of
GH start, although all agreed to the benefits of treating
before the onset of obesity, which often begins by 2 years
of age. All of these should be considered by physicians in
Asia, and correlated information should be sent to the pa-
tients’ parents as early as possible.
Conclusions
The early clinical manifestations of PWS are not specific,
and the disorder is easily confused with other nervous
system diseases, increasing the diagnostic challenge. But
it still has some special features in Asian neonates. If un-
explained hypotonia and feeding difficulty appear during
the neonatal period, clinicians should suspect PWS. In-
fants who exhibit the typical craniofacial features of
PWS should undergo genetic testing. When PWS is di-
agnosed, therapy should be instituted as early as pos-
sible. To optimize the prognosis for these patients, the
period of tube feeding should be shortened and parents
should be provided with health education.
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